In a broad variety of cancers, GSTs are involved in the resistance to several anticancer drugs by their conjugating activity (some examples are reported below)
The intracerebroventricular route used in all sleep studies is not clinically applicable
The following individuals require detailed medical evaluation before IV Glutathione therapy can be considered, and certain contraindications may result in deferral or modification: Pregnancy & Breastfeeding Phase Ongoing Skin or Body Infections Immune System Sensitivities Uncontrolled Sugar Levels Slow Recovery or Repair Conditions A detailed skin, wellness, and medical assessment is conducted before recommending Glutathione IV Drip Treatment in Mumbai
1.25mg GHK-Cu, 0.25mg TB-500, 0.25mg BPC-157 2.5mg GHK-Cu, 0.5mg TB-500, 0.5mg BPC-157 3.75mg GHK-Cu, 0.75mg TB-500, 0.75mg BPC-157 5mg GHK-Cu, 1mg TB-500, 1mg BPC-157 6.25mg GHK-Cu, 1.25mg TB-500, 1.25mg BPC-157 Recommended dosage is 1.25mg GHK-Cu, 0.25mg TB-500 and 0.25mg BPC-157 taken once daily
IC50 was calculated according to cell viability using the nonlinear regression analyses in GraphPad Prism 10.0 software
Mitochondrial GSH sequesters copper, preventing its binding to lipoylated proteins, such as DLAT, thereby blocking the aberrant protein oligomerization that drives this cell death pathway [109]
